OS Therapies Incorporated (OSTX) Stock Statistics & Valuation Metrics

OS Therapies Incorporated has a market cap or net worth of $76.61M. The enterprise value is $502.00M.

OS Therapies Incorporated has 44,538,105 shares outstanding. The number of shares has decreased by -2.65% in one year.

OS Therapies Incorporated’s return on equity (ROE) is 4.72 and return on invested capital (ROIC) is 582.87%.

The current PE Ratio of OS Therapies Incorporated is ―. OS Therapies Incorporated’s PEG ratio is -0.02.

In the last 12 months, OS Therapies Incorporated had revenue of 0.00 and earned -28.75M in profits. Earnings per share was -0.98.

In the last 12 months, operating cash flow was -14.24M and capital expenditures -466.42K, giving a free cash flow of -14.70M billion.

OS Therapies Incorporated pays an annual dividend of ―, resulting in a dividend yield of ―

OS Therapies Incorporated upcoming earnings date is Aug 13, 2026, Before Open (Confirmed).

OS Therapies Incorporated as a current ratio of 0.03, with Debt / Equity ratio of ―

In the past 12 months, OS Therapies Incorporated has paid 0.00 in taxes.

OS Therapies Incorporated EV to EBITDA ratio is -1.43, with an EV/FCF ratio of >-0.01.

OS Therapies Incorporated has $269.83K in cash and marketable securities with $1.34M in debt, giving a net cash position of $269.83K billion.

Gross margin is ―, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for OS Therapies Incorporated is $8.67, which is 11.43% higher than the current price. The consensus rating is Strong Buy